Brexogen, a biotechnology company specializing in exosome-based therapeutics, has signed a technology transfer and licensing ...
The U.S. Food and Drug Administration (FDA) has accepted for filing PTC Therapeutics’ New Drug Application (NDA) for ...
Biogen receives exclusive rights to commercialize zorevunersen outside U.S., Europe, and Japan.
Celonic Group, a “Pure Play” biologics contract development and manufacturing organization (CDMO), has signed a multi-year ...
Paul Owen has been appointed as Chief Executive Officer of YourBio Health, a pioneer in remote blood collection technology, and CEO-Partner of Flagship Pioneering, a bioplatform innovation company.
As a biologics CDMO focused on developing and manufacturing recombinant protein products using mammalian cell culture ...
The U.S. Food and Drug Administration (FDA) has granted Priority Review to Boehringer Ingelheim’s new drug application for zongertinib (BI 1810631) for the treatment of adult patients with ...